Schonfeld Strategic Advisors »

Summit Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 56k 21.90
2024-06-30 $171k 22k 7.80
2023-03-31 $83k 48k 1.75